



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

5045






                                    ANSWERED ON: 
                                

01.04.2022






Pharmaceutical Industry




Pritam Gopinath Munde













                                                    Girish Bhalchandra Bapat
                                                








                                                    Chandra Sekhar Sahu
                                                








                                                     Rahul Ramesh Shewale
                                                












                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















                                                    (a) whether the Government has recently issued any guidelines for the scheme for strengthening of Pharmaceutical Industry in the country; (b) if so, the details thereof along with the details of funds allocated for the said scheme; (c) whether the Government also proposes to improve the existing infrastructural facilities of the pharma sector in the country; (d) if so, the details thereof along with the targets fixed by the Government under the said scheme; and (e) the steps taken to establish India a global leader in the pharma sector?






ANSWER




                                                        MINISTER OF STATE IN THE MINISTRY OF CHEMICALS & FERTILIZERS                                       (SHRI BHAGWANTH KHUBA)(a) & (b): The Department has recently issued the guidelines of the scheme “Strengthening of Pharmaceutical Industry (SPI) in 11th March 2022 with the following objectives:•	To strengthen the existing infrastructure facilities in order to make India a global leader in the Pharma Sector by providing Financial assistance to pharma clusters for creation of Common Facilities.•	To upgrade the production facilities of SMEs and MSMEs, to meet national and international regulatory standards, by providing interest subvention or capital subsidy on their capital loans.•	To promote knowledge and awareness about the Pharmaceutical and Medical Devices Industry by taking up studies, building databases and brining industry leaders, academia and policy makers together to share their knowledge and experience.The total financial outlay of the scheme is Rs. 500 crore for a period of five years from 2021-22 to 2025-26.  (c) to (e): Department of Pharmaceuticals strives to improve the infrastructural facilities of the pharma sector in the country towards making India, a global leader in the sector.•	In order to make the country Atmanirbhar in pharmaceuticals, the Department of Pharmaceuticals has launched the Production Linked Incentives (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs), and Active Pharmaceuticals Ingredients (APIs) in India. The Total financial outlay of the scheme is Rs. 6,940 crore and the tenure from FY 2020-2021 to FY-2029-30.•	Another ‘Production Link Incentive (PLI) scheme for Pharmaceuticals has been launched with total financial outlay of Rs. 15,000 crore and tenure from FY 2020-2021 to FY 2028-29. The scheme intends to enhance India’s manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in pharmaceuticals sector. The eligible drugs under this scheme include APIs among other categories of pharmaceuticals products. •	The Department has launched a scheme to provide further support to API pharma companies through providing, financial assistance to the States for establishing three Bulk Drug Parks. •	Further, Department provides support to the pharma clusters for creating common infrastructure facilities under Assistance to Pharmaceuticals Industry for Common Facilities (API-CF).•	Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) has also been approved to support SME units in pharmaceutical sector for quality & technology upgradation. Details of all the above schemes can be accessed at https://pharmaceuticals.gov.in/schemes .*****
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113265196







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







